...
首页> 外文期刊>American Journal of Nephrology >Urinary collagen IV and piGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study.
【24h】

Urinary collagen IV and piGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study.

机译:尿胶原IV和piGST:潜在的生物标志物,用于检测糖尿病的局部肾脏损伤-一项先导研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Urinary biomarkers can identify damage to specific parts of the nephron. We performed a cross-sectional study to characterise the pattern of diabetic nephropathy using urinary biomarkers of glomerular fibrosis (collagen IV), proximal tubular damage (alpha-glutathione-S-transferase, GST) and distal tubular damage (piGST). METHODS: Clinical data from 457 unselected patients attending a hospital diabetes clinic were collected. Spot urine samples were analysed for albumin and creatinine. Biomarkers were measured by enzyme-linked immunosorbent assay, and corrected to urinary creatinine. RESULTS: All 3 biomarkers correlated weakly with albumin/creatinine ratios (Pearson correlation <0.2, p values <0.001). The most common abnormality was elevated urinary collagen IV (glomerular, 35%) compared to alphaGST (proximal tubule, 18%) or piGST (distal tubule, 15%). The proportion of patients with abnormal biomarker results increased across the normo-, micro- and macroalbuminuria groups, with collagen IV (26, 58, 65%) and piGST (11, 25, 35%) but not alphaGST. CONCLUSION: In patients with diabetes, these urinary biomarkers appear to identify renal damage that is related to, but distinct from, urine albumin/creatinine ratios. The markers of glomerular fibrosis and distal tubular damage related most closely to the degree of albuminuria. Longitudinal studies are now required to assess whether these biomarkers can detect early renal disease with greater specificity and sensitivity than the albumin/creatinine ratio.
机译:背景/目的:尿液生物标志物可以识别对肾单位特定部位的损害。我们进行了一项横断面研究,以使用肾小球纤维化(胶原蛋白IV),近端肾小管损伤(α-谷胱甘肽-S-转移酶,GST)和远端肾小管损伤(piGST)的尿液生物标志物来表征糖尿病性肾病的模式。方法:收集了457例未经选择的住院糖尿病门诊患者的临床数据。分析尿样中的白蛋白和肌酐。通过酶联免疫吸附测定法测量生物标志物,并校正为尿肌酐。结果:所有3种生物标志物与白蛋白/肌酐比值的相关性均较弱(Pearson相关性<0.2,p值<0.001)。与alphaGST(近端小管,18%)或piGST(远端小管,15%)相比,最常见的异常是尿胶原IV(肾小球,35%)升高。在正常,微量和大型白蛋白尿组中,具有生物标志物结果异常的患者比例有所增加,胶原蛋白IV(26、58、65%)和piGST(11、25、35%)却不包括alphaGST。结论:在糖尿病患者中,这些尿液生物标志物似乎可以识别与尿白蛋白/肌酐比值相关但又不同的肾脏损伤。肾小球纤维化和远端肾小管损伤的标志物与白蛋白尿程度最密切相关。现在需要进行纵向研究,以评估这些生物标记物是否能够以比白蛋白/肌酐比更高的特异性和敏感性来检测早期肾脏疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号